Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today positive phase I/II data on NXT007 in people with haemophilia A, ...

Francisco Roche, 35, pleaded guilty in February to conspiracy to distribute PCP and to unlawful possession of a firearm by a ...

Shares of Roche drew increased retail attention Monday after the Swiss drugmaker said it would move its investigational ...

Genentech, part of the Roche Group (OTCQX:RHHBY), said that a late-stage study testing Lunsumio, along with Polivy, showed ...

The decision to advance prasinezumab to Phase III was based on results from the Phase IIb PADOVA trial, which demonstrated ...

Mathieu Roche discusses the role of identity in digital advertising performance, emphasizing transparent data collection and ...

Roche's Venclexta failure does not affect the oncology pipeline, as HER2 franchise continues to drive revenue growth. Click ...

This well-tolerated investigational combination therapy avoids traditional chemotherapy and may be suitable for outpatient ...

Roche and AbbVie have come up short again in their effort to gain an additional indication for their blockbuster blood cancer ...

A suit cannot be maintained under the Civil law, merely based on an apprehension of litigation, without any concrete or ...

The commercial and clinical use of Elevidys was discontinued after two fatal cases of acute liver failure.